Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-04-05
2011-04-05
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S614000, C514S231500, C514S243000, C514S275000, C514S462000, C564S159000, C564S160000, C544S183000, C544S111000, C544S330000, C549S462000
Reexamination Certificate
active
07919528
ABSTRACT:
Novel PDF inhibitors and novel methods for their use are provided.
REFERENCES:
patent: 5691382 (1997-11-01), Crimmin et al.
patent: 6013792 (2000-01-01), Castelhano et al.
patent: 6028110 (2000-02-01), Miller et al.
patent: 6037472 (2000-03-01), Castelhano et al.
patent: 7019003 (2006-03-01), Xiang et al.
patent: WO00/35440 (2000-06-01), None
patent: WO00/42026 (2000-07-01), None
patent: WO 02/16315 (2002-02-01), None
patent: WO02 070541 (2002-09-01), None
patent: WO2004/052919 (2004-06-01), None
patent: WO 2005/005456 (2005-01-01), None
patent: WO2005/017124 (2005-02-01), None
patent: WO2006/055663 (2005-05-01), None
patent: WO2009/061879 (2009-05-01), None
Snyder et al., J. Med. Liban 48(4): 208-214, 2000.
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Groche, Dieter, “Isolation and Crystallization of Functionally CompetentEscherichia coliPeptide Deformylase forms Containing either Iron or Nickel in the Active Site,”Biochemical and Biophysical Research Communications, 246, 342-346 (1998) Article No. RC988616.
Chen, Dawn Z., “Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor,”Biochemistry39, 1256-1263 (2000).
Giglione, Carmela, “Peptide Deformylase as a target for new generation, broad spectrum antimicrobial agents,” 36(6), 1197-1205 (2000).
Huntington, Kristi M., “Synthesis and Antibacterial Activity of Peptide Deformylase Inhibitors,”Biochemistry, 39, 4543-4551 (2000).
Apfel, Christian, “Hydroxamic Acid Derivatives as Potent Peptide Deformylase Inhibitors and Antibacterial Agents,”J. Med. Chem, 43, 2324-2331 (2000).
Clements, John M., “Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor,”Antimicrobial Agents and Chemotherapy, 45(2), 563-570 (Feb. 2001).
Aubart Kelly M.
Benowitz Andrew B.
Christensen, IV Siegfried B.
Karpinski Joseph M.
Lee Jinhwa
Balasubramanian Venkataraman
Furman Theodore R.
GlaxoSmithKline LLC
Madden Laura K.
LandOfFree
Peptide deformylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide deformylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide deformylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702247